Evaluation of potential serum analytes for individuals at-risk of multiple sclerosis
Kristin Mounts, Yunduo Liu, Masashi Fujita, Juliana Oyegunle, Tradite Neziraj, Susan V. Pollak, Renu Nandakumar, Nyater Ngouth, Sonya U. Steele, Irene C. M. Cortese, Charles C. White, Steven Jacobson, Daniel S. Reich, Philip L. De Jager
This study evaluates six potential serum biomarkers for multiple sclerosis in at-risk individuals and finds most are not robust predictors, though SPP1 shows a significant inverse correlation with genetic risk.
bioRxiv · Apr 29, 2026 · PreprintImmunology